Sunovion Gets 2 Latuda Generics Blocked, Sues Over A 3rd
A New Jersey federal judge on Tuesday blocked Emcure Pharmaceuticals Ltd. and Teva Pharmaceutical Industries Ltd. from moving forward with generic versions of Sunovion Pharmaceuticals Inc.'s bipolar disorder medication Latuda, and...To view the full article, register now.
Already a subscriber? Click here to view full article